US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 124.340
  • -1.170-0.93%
Trading Nov 14 10:41 ET
12.59BMarket Cap33.16P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurocrine Biosciences Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
602.78M
622.10M
+19.32M
Beat Est.
+20.85%
+24.72%
+3.21%
EPS
1.45
1.24
-0.21
Miss Est.
+76.48%
+51.22%
-14.31%
Analyst Rating
Strong Buy

Nov 14, 2024

Neurocrine Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 623.871M --
-- 2024/Q4 -- / 630.017M --
Oct 30, 2024 2024/Q3 622.100M / 602.780M --
Aug 1, 2024 2024/Q2 590.200M / 546.595M --
May 1, 2024 2024/Q1 515.300M / 512.006M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 623.871M--
--2024/Q4-- / 630.017M--
Oct 30, 20242024/Q3622.100M / 602.780M--
Aug 1, 20242024/Q2590.200M / 546.595M--
May 1, 20242024/Q1515.300M / 512.006M--

Unlock Free Earnings Estimates

Neurocrine Biosciences Earnings Reports

  • Neurocrine Biosciences | 10-Q: Q3 2024 Earnings Report

    Oct 30 19:07

  • Neurocrine Biosciences | 10-Q: Q2 2024 Earnings Report

    Aug 1 19:07

  • Neurocrine Biosciences | 10-Q: Q1 2024 Earnings Report

    May 1 19:09

  • Neurocrine Biosciences | 10-K: FY2023 Annual Report

    Feb 10 06:31

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Strong Buy

    • Buy

      80.95%

    • Hold

      19.05%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data